Improving Oral Bioavailability of Sorafenib by Optimizing the “Spring” and “Parachute” Based on Molecular Interaction Mechanisms
Author:
Affiliation:
1. School of Pharmaceutical Sciences and Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Tsinghua University, Beijing 100084, China
2. College of Pharmaceutical Sciences, Soochow University, Suzhou 215006, China
Funder
National Natural Science Foundation of China
Central Committee of the Communist Party of China
Center for Life Sciences
Beijing Municipal Science and Technology Commission
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.5b00837
Reference34 articles.
1. Discovery and development of sorafenib: a multikinase inhibitor for treating cancer
2. Sorafenib Blocks the RAF/MEK/ERK Pathway, Inhibits Tumor Angiogenesis, and Induces Tumor Cell Apoptosis in Hepatocellular Carcinoma Model PLC/PRF/5
3. Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
4. CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations
5. US Food and Drug Administration. Sorafenib (Nexavar) prescribing information ( 2005) .
Cited by 130 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Torsemide Crystalline Salts with a Significant Spring-Parachute Effect;AAPS PharmSciTech;2024-09-07
2. Investigation of magnesium aluminometasilicate (Neusilin US2) based surface solid dispersion of sorafenib tosylate using QbD approach: In vitro and in vivo pharmacokinetic study;ADMET and DMPK;2024-08-09
3. Pharmacokinetic and Biodistribution Studies of Camel Milk Casein Nanoparticles Loaded Sorafenib in Swiss Albino Mice;BioNanoScience;2024-06-07
4. Effect of food on oral pharmacokinetics of edaravone coamorphous dispersion containing bile salts as coformers – Part II;Annales Pharmaceutiques Françaises;2024-06
5. Development of posaconazole nanocrystalline solid dispersion: preparation, characterization and in vivo evaluation;Pharmaceutical Development and Technology;2024-05-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3